Page last updated: 2024-08-21

cyclopentane and B-Cell Chronic Lymphocytic Leukemia

cyclopentane has been researched along with B-Cell Chronic Lymphocytic Leukemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bravo-Navas, S; Briz, M; Domínguez-García, JJ; Pipaón, C; Romón, Í; Yáñez, L1
Brown, JR; Danilov, AV; Danilova, OV; Eastman, A; Godbersen, JC; Humphries, LA; Kebbekus, PE1
Berger, A; Brown, JR; Danilov, AV; Danilova, OV; Godbersen, JC; Paiva, C1
Berger, A; Brown, JR; Danilov, AV; Godbersen, JC; Paiva, C1
Blickstein, D; Fingrut, O; Flescher, E; Heyfets, A; Rotem, R; Shaklai, M1

Other Studies

5 other study(ies) available for cyclopentane and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Map of ubiquitin-like post-translational modifications in chronic lymphocytic leukemia. Role of p53 lysine 120 NEDDylation.
    Leukemia, 2021, Volume: 35, Issue:12

    Topics: Cells, Cultured; Cyclopentanes; Enzyme Inhibitors; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lysine; Mass Spectrometry; NEDD8 Protein; Protein Processing, Post-Translational; Pyrimidines; Tumor Suppressor Protein p53; Ubiquitins

2021
The Nedd8-activating enzyme inhibitor MLN4924 thwarts microenvironment-driven NF-κB activation and induces apoptosis in chronic lymphocytic leukemia B cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2014, Mar-15, Volume: 20, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; B-Lymphocytes; Blotting, Western; Cell Line, Tumor; Cyclopentanes; Enzyme Inhibitors; Flow Cytometry; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; NF-kappa B; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Pyrimidines; Real-Time Polymerase Chain Reaction; Signal Transduction; Tumor Microenvironment; Ubiquitin-Activating Enzymes

2014
Targeting neddylation effectively antagonizes nuclear factor-κB in chronic lymphocytic leukemia B-cells.
    Leukemia & lymphoma, 2015, Volume: 56, Issue:5

    Topics: Apoptosis; Cell Line, Tumor; Cyclopentanes; Gene Expression Regulation, Leukemic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; NEDD8 Protein; NF-kappa B; Pyrimidines; Transcription, Genetic; Ubiquitins

2015
Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents.
    Cell death & disease, 2015, Jul-09, Volume: 6

    Topics: Alkylating Agents; Apoptosis; B-Lymphocytes; Bendamustine Hydrochloride; CD40 Antigens; CD40 Ligand; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; DNA Damage; Gene Expression Regulation, Neoplastic; Humans; Interleukins; Leukemia, Lymphocytic, Chronic, B-Cell; NEDD8 Protein; NF-kappa B; Pyrimidines; Ubiquitin-Activating Enzymes; Ubiquitins

2015
Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria.
    Cancer research, 2005, Mar-01, Volume: 65, Issue:5

    Topics: Acetates; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Calcium; Carcinoma, Hepatocellular; Cell Membrane Permeability; Cells, Cultured; Cyclopentanes; Cytochromes c; Fibroblasts; Flow Cytometry; Humans; Ion Channels; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Neoplasms; Lymphocytes; Membrane Potentials; Mice; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; Oxylipins; Plant Growth Regulators

2005